Seelos Therapeutics, Inc. (SEEL)
NASDAQ: SEEL · IEX Real-Time Price · USD
0.291
+0.005 (1.89%)
At close: Apr 26, 2024, 4:00 PM
0.292
+0.001 (0.34%)
After-hours: Apr 26, 2024, 7:28 PM EDT
Seelos Therapeutics Stock Forecast
SEEL's stock price has decreased by -98.53% in the past year and price targets may not have had time to catch up.
Stock Price Forecast
The 2 analysts with 12-month price forecasts for Seelos Therapeutics stock have an average target of 75, with a low estimate of 30 and a high estimate of 120. The average target predicts an increase of 25,673.20% from the current stock price of 0.29.
Analyst Consensus: Buy
* Price targets were last updated on Sep 21, 2023.
Analyst Ratings
The average analyst rating for SEEL stock from 4 stock analysts is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Nov '23 | Dec '23 | Jan '24 | Feb '24 | Mar '24 | Apr '24 |
|---|---|---|---|---|---|---|
| Strong Buy | 1 | 1 | 1 | 1 | 1 | 1 |
| Buy | 1 | 1 | 1 | 1 | 1 | 1 |
| Hold | 2 | 2 | 2 | 2 | 2 | 2 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 4 | 4 | 4 | 4 | 4 | 4 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Guggenheim | Guggenheim | Strong Buy → Hold Downgrades n/a | Strong Buy → Hold | Downgrades | n/a | n/a | Sep 22, 2023 |
| Benchmark | Benchmark | Buy Maintains $120 → $30 | Buy | Maintains | $120 → $30 | +10,209.28% | Sep 21, 2023 |
| Guggenheim | Guggenheim | Strong Buy → Hold Downgrades n/a | Strong Buy → Hold | Downgrades | n/a | n/a | Sep 21, 2023 |
| Cantor Fitzgerald | Cantor Fitzgerald | Buy → Hold Downgrades n/a | Buy → Hold | Downgrades | n/a | n/a | Sep 21, 2023 |
| Cantor Fitzgerald | Cantor Fitzgerald | Buy Reiterates $60 | Buy | Reiterates | $60 | +20,518.56% | Aug 22, 2023 |
Financial Forecast
Revenue This Year
306.00K
from 2.20M
Decreased by -86.11%
Revenue Next Year
28.97M
from 306.00K
Increased by 9,366.67%
EPS This Year
-1.34
from -7.73
EPS Next Year
-0.33
from -1.34
Revenue Forecast
| Revenue | 2024 | 2025 |
|---|---|---|
| High | 945,000 | 29.8M |
| Avg | 306,000 | 29.0M |
| Low | n/a | 27.8M |
Revenue Growth
| Revenue Growth | 2024 | 2025 |
|---|---|---|
| High | -57.1% | 9,645.1% |
| Avg | -86.1% | 9,366.7% |
| Low | - | 8,995.4% |
EPS Forecast
| EPS | 2024 | 2025 |
|---|---|---|
| High | -1.38 | -0.34 |
| Avg | -1.34 | -0.33 |
| Low | -1.28 | -0.31 |
EPS Growth
| EPS Growth | 2024 | 2025 |
|---|---|---|
| High | - | - |
| Avg | - | - |
| Low | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.